HBIOHarvard Bioscience, Inc.
6.488USD+11.09%Mkt Cap: 29.07M USDP/E: Last update: 2026-06-01

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offer…

Indicators:|

Key Statistics

Company
Market Cap29.07M USD
Enterprise Value63.54M USD
Revenue (TTM)85.53M USD
Gross Profit49.91M USD
Net Income (TTM)-56.70M USD
Revenue/Share19.20 USD
Last Price6.488 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees316
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINUS4169061052
Valuation
P/E (Trailing)
P/E (Forward)13.36
PEG1.31
EV/EBITDA8.12
EV/Revenue0.74
P/S0.31
P/B2.62
EPS (TTM)-2.15
EPS (Forward)0.44
52W Range
3.70049% of range9.400
52W High9.400 USD
52W Low3.700 USD
Profitability
Gross Margin57.67%
Oper. Margin-4.52%
EBITDA Margin9.15%
Profit Margin-65.51%
ROE-412.84%
ROA-70.81%
Growth
Revenue Growth-4.70%
Earnings Growth
Cash Flow & Leverage
Operating CF6.73M USD
CapEx (TTM)1.86M USD
FCF Margin9.17%
FCF Yield26.98%
Net Debt37.02M USD
Net Debt/EBITDA4.73
Balance Sheet
Debt/Equity3.22
Current Ratio1.99
Quick Ratio0.91
Book Value/Sh2.246 USD
Cash/Share1.574 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:10
Split DateMar 16, 2026
Analyst Consensus
Rating
Target (Mean)6.000 USD
Target Range6.000 USD6.000 USD
# Analysts1
Ownership
Shares Out.4.51M
Float3.53M
Insiders7.65%
Institutions45.05%
Short Interest
Short Ratio2.8d
Short % Float2.73%
Short % Out.2.68%
Shares Short120.93K
Short (prev mo.)243.45K
Technical
SMA 505.743 (+13.0%)
SMA 2005.615 (+15.6%)
Beta1.57
S&P 52W Chg27.94%
Avg Vol (30d)34.99K
Avg Vol (10d)29.44K
Technical Indicators
RSI (14)50.3
MACD-0.0913
MACD Signal-0.0901
MACD Hist.-0.0012
BB Upper7.271 USD
BB Middle5.930 USD
BB Lower4.589 USD
BB Width45.23%
ATR (14)0.4309 USD
Vol Ratio (20d)0.28x